Top Buy
| Security | Buy ▲ | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| SCYNEXIS Inc. | 5 | 0 | 0 | 0 | €1.81 | €8.35 | 360.971% |
| Corvus Pharmaceuticals Inc | 5 | 1 | 0 | 0 | €1.62 | €6.45 | 298.309% |
| Eledon Pharmaceuticals Inc. | 6 | 0 | 0 | 0 | €2.24 | €12.21 | 445.129% |
| Deciphera Pharmaceuticals | 6 | 0 | 0 | 0 | €23.80 | €24.97 | 4.929% |
| Enanta Pharmaceuticals Inc. | 6 | 4 | 0 | 0 | €12.50 | €25.58 | 104.624% |
| Xeris Biopharma Holdings Inc. | 6 | 0 | 0 | 0 | €1.92 | €4.39 | 128.833% |
| Codexis Inc. | 7 | 2 | 0 | 0 | €2.75 | €8.36 | 203.384% |
| Amicus Therapeutics Inc. | 7 | 0 | 0 | 0 | €9.10 | €17.64 | 93.821% |
| Viking Therapeutics Inc | 7 | 0 | 2 | 0 | €47.58 | €62.50 | 31.358% |
| AnaptysBio Inc | 8 | 1 | 0 | 0 | €23.40 | €45.21 | 93.205% |
| Agios Pharmaceuticals Inc. | 8 | 1 | 1 | 1 | €38.20 | €43.87 | 14.840% |
| Adverum Biotechnologies Inc. | 8 | 0 | 1 | 0 | €1.38 | €13.07 | 847.449% |
| Syros Pharmaceuticals Inc. | 8 | 1 | 2 | 0 | €4.68 | €13.60 | 190.545% |
| Sarepta Therapeutics | 9 | 0 | 8 | 0 | €139.40 | €180.00 | 29.125% |
| Biocryst Pharmaceuticals | 9 | 0 | 0 | 0 | €6.01 | €11.05 | 83.814% |
| Chromadex Corp | 10 | 1 | 1 | 0 | €2.32 | €5.55 | 139.379% |
| Heron Therapeutics Inc. | 12 | 1 | 1 | 0 | €2.74 | €4.60 | 67.920% |
| Incyte Corp. | 12 | 3 | 0 | 1 | €53.62 | €78.05 | 45.556% |
| Verastem Inc. | 12 | 0 | 2 | 0 | €2.42 | €18.50 | 664.380% |
| MacroGenics Inc. | 13 | 0 | 0 | 0 | €3.89 | €12.42 | 219.401% |
| Medpace Holdings Inc | 13 | 0 | 2 | 0 | €376.10 | €420.00 | 11.672% |
| Catalyst Pharmaceutical Partners Inc | 14 | 0 | 0 | 0 | €14.00 | €24.13 | 72.380% |
| Rigel Pharmaceutical Inc. | 14 | 0 | 3 | 0 | €0.74 | €13.82 | 1767.203% |
| Xencor Inc. | 14 | 1 | 4 | 0 | €16.50 | €31.70 | 92.100% |